Elevation of micronuclei frequency in mouse bone marrow treated with various doses of teniposide (VM-26)

Ganesh C. Jagetia, R. Aruna

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The effect of various doses (0-10 mg/kg body wt.) of teniposide (VM-26) was studied on the induction of micronuclei at 12, 24 and 36 h post-treatment. The frequency of micronuclei (MPCE and MNCE) increased in a dose-dependent manner up to a dose of 0.3125 mg/kg VM-26, where a peak frequency of micronuclei was observed. A further increase in the drug dose resulted in the reduction in micronuclei frequency in comparison with 0.3125 mg/kg drug dose reaching a nadir at 10 mg/kg. However, it was significantly higher than DDW (double distilled water) treated controls. The pattern of micronuclei induction was similar for all the post-treatment time periods. The frequency of micronuclei also increased with scoring time and the highest frequency of micronuclei was observed at 24 h post-treatment, which declined thereafter without restoration to DDW treated control level. Conversely, the PCE/NCE ratio registered a dose-dependent decline after treatment of mice with various doses of VM-26. A peak decline was observed at a dose of 0.3125 mg/kg, thereafter the decline became consistently less resulting in an elevation in the PCE/NCE ratio in comparison with 0.3125 mg/kg VM-26. Copyright (C) 1999 Elsevier Science Ireland Ltd.

Original languageEnglish
Pages (from-to)203-210
Number of pages8
JournalToxicology Letters
Volume104
Issue number3
DOIs
Publication statusPublished - 22-02-1999
Externally publishedYes

Fingerprint

Teniposide
Bone
Bone Marrow
Water
Level control
Pharmaceutical Preparations
Restoration

All Science Journal Classification (ASJC) codes

  • Toxicology

Cite this

@article{3b4d64789823413db14f116696bcbc05,
title = "Elevation of micronuclei frequency in mouse bone marrow treated with various doses of teniposide (VM-26)",
abstract = "The effect of various doses (0-10 mg/kg body wt.) of teniposide (VM-26) was studied on the induction of micronuclei at 12, 24 and 36 h post-treatment. The frequency of micronuclei (MPCE and MNCE) increased in a dose-dependent manner up to a dose of 0.3125 mg/kg VM-26, where a peak frequency of micronuclei was observed. A further increase in the drug dose resulted in the reduction in micronuclei frequency in comparison with 0.3125 mg/kg drug dose reaching a nadir at 10 mg/kg. However, it was significantly higher than DDW (double distilled water) treated controls. The pattern of micronuclei induction was similar for all the post-treatment time periods. The frequency of micronuclei also increased with scoring time and the highest frequency of micronuclei was observed at 24 h post-treatment, which declined thereafter without restoration to DDW treated control level. Conversely, the PCE/NCE ratio registered a dose-dependent decline after treatment of mice with various doses of VM-26. A peak decline was observed at a dose of 0.3125 mg/kg, thereafter the decline became consistently less resulting in an elevation in the PCE/NCE ratio in comparison with 0.3125 mg/kg VM-26. Copyright (C) 1999 Elsevier Science Ireland Ltd.",
author = "Jagetia, {Ganesh C.} and R. Aruna",
year = "1999",
month = "2",
day = "22",
doi = "10.1016/S0378-4274(98)00368-3",
language = "English",
volume = "104",
pages = "203--210",
journal = "Toxicology Letters",
issn = "0378-4274",
publisher = "Elsevier BV",
number = "3",

}

Elevation of micronuclei frequency in mouse bone marrow treated with various doses of teniposide (VM-26). / Jagetia, Ganesh C.; Aruna, R.

In: Toxicology Letters, Vol. 104, No. 3, 22.02.1999, p. 203-210.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Elevation of micronuclei frequency in mouse bone marrow treated with various doses of teniposide (VM-26)

AU - Jagetia, Ganesh C.

AU - Aruna, R.

PY - 1999/2/22

Y1 - 1999/2/22

N2 - The effect of various doses (0-10 mg/kg body wt.) of teniposide (VM-26) was studied on the induction of micronuclei at 12, 24 and 36 h post-treatment. The frequency of micronuclei (MPCE and MNCE) increased in a dose-dependent manner up to a dose of 0.3125 mg/kg VM-26, where a peak frequency of micronuclei was observed. A further increase in the drug dose resulted in the reduction in micronuclei frequency in comparison with 0.3125 mg/kg drug dose reaching a nadir at 10 mg/kg. However, it was significantly higher than DDW (double distilled water) treated controls. The pattern of micronuclei induction was similar for all the post-treatment time periods. The frequency of micronuclei also increased with scoring time and the highest frequency of micronuclei was observed at 24 h post-treatment, which declined thereafter without restoration to DDW treated control level. Conversely, the PCE/NCE ratio registered a dose-dependent decline after treatment of mice with various doses of VM-26. A peak decline was observed at a dose of 0.3125 mg/kg, thereafter the decline became consistently less resulting in an elevation in the PCE/NCE ratio in comparison with 0.3125 mg/kg VM-26. Copyright (C) 1999 Elsevier Science Ireland Ltd.

AB - The effect of various doses (0-10 mg/kg body wt.) of teniposide (VM-26) was studied on the induction of micronuclei at 12, 24 and 36 h post-treatment. The frequency of micronuclei (MPCE and MNCE) increased in a dose-dependent manner up to a dose of 0.3125 mg/kg VM-26, where a peak frequency of micronuclei was observed. A further increase in the drug dose resulted in the reduction in micronuclei frequency in comparison with 0.3125 mg/kg drug dose reaching a nadir at 10 mg/kg. However, it was significantly higher than DDW (double distilled water) treated controls. The pattern of micronuclei induction was similar for all the post-treatment time periods. The frequency of micronuclei also increased with scoring time and the highest frequency of micronuclei was observed at 24 h post-treatment, which declined thereafter without restoration to DDW treated control level. Conversely, the PCE/NCE ratio registered a dose-dependent decline after treatment of mice with various doses of VM-26. A peak decline was observed at a dose of 0.3125 mg/kg, thereafter the decline became consistently less resulting in an elevation in the PCE/NCE ratio in comparison with 0.3125 mg/kg VM-26. Copyright (C) 1999 Elsevier Science Ireland Ltd.

UR - http://www.scopus.com/inward/record.url?scp=0032990676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032990676&partnerID=8YFLogxK

U2 - 10.1016/S0378-4274(98)00368-3

DO - 10.1016/S0378-4274(98)00368-3

M3 - Article

VL - 104

SP - 203

EP - 210

JO - Toxicology Letters

JF - Toxicology Letters

SN - 0378-4274

IS - 3

ER -